RxSight Plunges 37.29% on Revenue Miss

On July 9, 2025, RxSight's stock experienced a significant drop of 37.29% in pre-market trading, marking a substantial decline in its share price.

RxSight, Inc. recently announced its preliminary financial results for the second quarter of 2025, revealing a 4% decrease in revenue compared to the same period last year. The company reported an estimated revenue of approximately $33.6 million for the quarter, which fell short of market expectations.

In response to the underperformance, RxSight has revised its full-year 2025 guidance downward. The company now expects revenue to be between $120.0 million and $125.0 million, a significant reduction from previous projections. This adjustment reflects the challenges faced by the company in maintaining its revenue growth.

RxSight plans to release its complete second-quarter financial results on August 7, 2025. The preliminary results announced are subject to the completion of financial statements and may be adjusted accordingly. The company's decision to cut its revenue guidance has raised concerns among investors about its future performance and strategic direction.